AVACHECK
Live / Applied — First extension granted (statement of use) (as of 25 Nov 2025)
What this means for you
Not registered yet, but its 22 May 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98562952
- Mark type
- Stylized text
- Filed
- 22 May 2024
- Published for opposition
- 07 Jan 2025
- Attorney of record
- Beth Felix
Goods and services
- Class 005 — Pharmaceuticals: Diagnostic kits comprising diagnostic agents, preparations and substances for medical purposes; Diagnostic test reagents for medical purposes; Diagnostic kits comprising diagnostic agents, preparations and substances for medical use; Diagnostic preparations for medical purposes; all of the foregoing excluding diagnostic agents, preparations, substances and reagents for use in glucose monitoring and diabetes care
Owner
- Azure Biotech, Inc., Houston, TX, US
- Azure Biotech, Inc., Houston, TX, US
Prosecution history
- 26 Nov 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 25 Nov 2025 — SOU EXTENSION 1 GRANTED
- 25 Nov 2025 — SOU EXTENSION 1 FILED
- 25 Nov 2025 — SOU TEAS EXTENSION RECEIVED
- 24 Jun 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 18 May 2025 — EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
- 05 May 2025 — POST PUBLICATION AMENDMENT - ENTERED
- 29 Apr 2025 — ASSIGNED TO PETITION STAFF
- 24 Mar 2025 — TEAS POST PUBLICATION AMENDMENT RECEIVED
- 06 Feb 2025 — EXTENSION OF TIME TO OPPOSE RECEIVED
- 07 Jan 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 07 Jan 2025 — PUBLISHED FOR OPPOSITION
- 01 Jan 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 10 Dec 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 10 Dec 2024 — EXAMINER'S AMENDMENT ENTERED